Insider · CIK 0001041126

FELLOWS DAVID A

Reports to the SEC for 3 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001041126

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,828 sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.5K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,183 sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.7K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2026-02-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,828 sh	—	—	2,828
2025-06-11	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-02-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,650
2024-07-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,183 sh	—	—	8,183
2024-06-10	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2023-06-12	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2022-06-16	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2021-09-28	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-06-07	Nightstar Therapeutics plcD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−617K sh	$25.50	−$15.7M	0
2019-06-07	Nightstar Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−271K sh	$10.76	−$2.92M	0
2019-06-07	Nightstar Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−220K sh	$11.26	−$2.48M	0
2019-04-01	Nightstar Therapeutics plcS Sale	Director, Chief Executive Officer	SSale	−9,305 sh	$25.31	−$236K	617,090
2019-01-22	Nightstar Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+271K sh	—	—	271,100
2019-01-07	Nightstar Therapeutics plcS Sale	Director, Chief Executive Officer	SSale	−8,733 sh	$12.98	−$113K	630,826
2019-01-07	Nightstar Therapeutics plcS Sale	Director, Chief Executive Officer	SSale	−8,733 sh	$12.98	−$113K	626,395
2003-11-03	ALLERGAN INCI Discretionary Transaction	CVP, Pres., EuroAsia/Africa/ME	IDiscretionary Transaction	−4,000 sh	$75.21	−$301K	2,332.405
2003-10-30	ALLERGAN INCM Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	+21.5K sh	$13.01	+$280K	30,506.41
2003-10-30	ALLERGAN INCS Sale	CVP, Pres., EuroAsia/Africa/ME	SSale	−21.5K sh	$76.06	−$1.64M	8,986.41
2003-10-30	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	−21.5K sh	$76.06	−$1.64M	0
2003-10-28	ALLERGAN INCM Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	+20K sh	$13.01	+$260K	28,986.41
2003-10-28	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	−20K sh	$70.06	−$1.4M	21,520
2003-10-28	ALLERGAN INCS Sale	CVP, Pres., EuroAsia/Africa/ME	SSale	−20K sh	$76.06	−$1.52M	8,986.41
2003-10-24	ALLERGAN INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	+14.7K sh	$13.00	+$192K	70,998
2003-10-24	ALLERGAN INCS Sale	CVP, Pres., EuroAsia/Africa/ME	SSale	−14.7K sh	$76.54	−$1.13M	8,986.41
2003-10-24	ALLERGAN INCM Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	+14.7K sh	$13.01	+$192K	23,725.41
1997-11-25	ALLERGAN INCEmployee Stock Option (right to buy)M Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	−686 sh	—	—	74,377
1997-11-25	ALLERGAN INCS Sale	CVP, Pres., EuroAsia/Africa/ME	SSale	−686 sh	$34.00	−$23.3K	3,175.8
1997-11-25	ALLERGAN INCM Exercise/Conversion	CVP, Pres., EuroAsia/Africa/ME	MExercise/Conversion	+686 sh	$19.25	+$13.2K	—

Recent filings

Accepted (ET)
May 54
FELLOWS DAVID A0001041126-26-000004
SEC(opens sec.gov)
Feb 24
FELLOWS DAVID A0001041126-26-000002
SEC(opens sec.gov)
Jun 124
FELLOWS DAVID A0001562180-25-004755
SEC(opens sec.gov)
Feb 34
FELLOWS DAVID A0001562180-25-000854
SEC(opens sec.gov)
Jul 24
FELLOWS DAVID A0001562180-24-005545
SEC(opens sec.gov)
Jun 144
FELLOWS DAVID A0001562180-24-005100
SEC(opens sec.gov)
Jun 144
FELLOWS DAVID A0001562180-23-005170
SEC(opens sec.gov)
Jun 214
FELLOWS DAVID A0001562180-22-005267
SEC(opens sec.gov)
Sep 304
FELLOWS DAVID A0000899243-21-038538
SEC(opens sec.gov)
Jun 74
FELLOWS DAVID A0001209191-19-035557
SEC(opens sec.gov)

Companies

Address

C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100

FOSTER CITY, CA, 94404